Literature DB >> 23587525

Impact of mitral annular calcification on early and late outcomes following mitral valve repair of myxomatous degeneration.

Vincent Chan1, Marc Ruel, Mark Hynes, Sophia Chaudry, Thierry G Mesana.   

Abstract

OBJECTIVES: Mitral annular calcification is associated with significant morbidity and mortality at the time of mitral valve surgery. However, few data are available describing the impact of mitral annular calcification on early and late outcomes following mitral valve repair in the current era.
METHODS: Between 2001 and 2011, 625 patients were referred for mitral valve repair of severe mitral regurgitation due to myxomatous degeneration. The mean patient age was 63.9 ± 12.7 years and 164 (26%) were female. Concomitant coronary artery bypass grafting was performed in 91 (15%) and 24 (4%) had previous cardiac surgery. Calcification of the mitral annulus was observed in 119 patients (19%), of whom complete debridement and extensive annulus reconstruction were performed in 14. The mean follow-up was for 2.4 ± 2.3 years.
RESULTS: There were no deaths within 30 days of surgery. Risk factors associated with mitral annular calcification included older age (odds ratio 1.05 ± 0.02 per increasing year), female gender (odds ratio 1.88 ± 0.42) and larger preoperative left atrial size (odds ratio 1.04 ± 0.03 per increasing mm) (all P<0.01). Severe renal impairment defined as a creatinine clearance <30 mL/min was observed in 9 patients, all of whom had mitral annular calcification. Intraoperative conversion to mitral valve replacement was performed in 19 patients (97% repair rate), 5 of whom had mitral annular calcification. Extension of mitral annular calcification into one or more leaflet scallops was observed for all patients who required conversion to valve replacement. Five-year survival, freedom from recurrent mitral regurgitation ≥ 2+ and freedom from recurrent mitral regurgitation ≥ 3+ was 88.1 ± 2.4, 89.6 ± 2.3 and 97.8 ± 0.8%, respectively. Mitral annular calcification was not associated with survival or recurrent mitral regurgitation.
CONCLUSIONS: Risk factors for mitral annular calcification in patients with myxomatous degeneration and severe mitral regurgitation include older age, female gender, severe renal dysfunction and larger preoperative left atrial size. Nevertheless, favourable early and late results can be achieved with mitral valve repair in this population.

Entities:  

Keywords:  Follow-up studies; Mitral regurgitation; Mitral valve repair; Survival; Valves

Mesh:

Year:  2013        PMID: 23587525      PMCID: PMC3686409          DOI: 10.1093/icvts/ivt163

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  15 in total

1.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography.

Authors:  William A Zoghbi; Maurice Enriquez-Sarano; Elyse Foster; Paul A Grayburn; Carol D Kraft; Robert A Levine; Petros Nihoyannopoulos; Catherine M Otto; Miguel A Quinones; Harry Rakowski; William J Stewart; Alan Waggoner; Neil J Weissman
Journal:  J Am Soc Echocardiogr       Date:  2003-07       Impact factor: 5.251

2.  Unusual complications during mitral valve replacement in the presence of calcification of the annulus.

Authors:  H MacVaugh; C R Joyner; J Johnson
Journal:  Ann Thorac Surg       Date:  1971-04       Impact factor: 4.330

3.  Mitral repair in patients with severely calcified annulus: feasibility, surgery and results.

Authors:  Roland Fasol; Katja Mahdjoobian; Elrina Joubert-Hubner
Journal:  J Heart Valve Dis       Date:  2002-03

4.  Valve repair in mitral regurgitation complicated by severe annulus calcification.

Authors:  C K Ng; C Punzengruber; O Pachinger; J Nesser; H Auer; H Franke; P Hartl
Journal:  Ann Thorac Surg       Date:  2000-07       Impact factor: 4.330

5.  Decalcification of the mitral annulus: surgical experience in 81 patients.

Authors:  M Dietrich; M Doss; T Aybek; S Martens; M Scherer; G Wimmer-Greinecker; A Moritz
Journal:  Thorac Cardiovasc Surg       Date:  2006-10       Impact factor: 1.827

6.  Reconstruction of the mitral anulus. A ten-year experience.

Authors:  T E David; C M Feindel; S Armstrong; Z Sun
Journal:  J Thorac Cardiovasc Surg       Date:  1995-11       Impact factor: 5.209

7.  Mitral valve surgery in patients with extensive calcification of the mitral annulus.

Authors:  Christopher M Feindel; Zafar Tufail; Tirone E David; Joan Ivanov; Susan Armstrong
Journal:  J Thorac Cardiovasc Surg       Date:  2003-09       Impact factor: 5.209

8.  Pathological and clinical study of calcification of the mitral valve ring.

Authors:  A Pomerance
Journal:  J Clin Pathol       Date:  1970-05       Impact factor: 3.411

9.  Mitral annulus calcification: determinants of repair feasibility, early and late surgical outcome.

Authors:  Cosimo d'Alessandro; Nicola Vistarini; Stéphane Aubert; Frédérique Jault; Christophe Acar; Alain Pavie; Iradj Gandjbakhch
Journal:  Eur J Cardiothorac Surg       Date:  2007-08-15       Impact factor: 4.191

10.  Extensive calcification of the mitral valve anulus: pathology and surgical management.

Authors:  A F Carpentier; M Pellerin; J F Fuzellier; J Y Relland
Journal:  J Thorac Cardiovasc Surg       Date:  1996-04       Impact factor: 5.209

View more
  2 in total

1.  eComment. Qualitative assesment of mitral annular calcification.

Authors:  Ugur Kucuk; Hilal Olgun Kucuk; Sait Demirkol; Sevket Balta
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07

2.  Randomised trial of mitral valve repair with leaflet resection versus leaflet preservation on functional mitral stenosis (The CAMRA CardioLink-2 Trial).

Authors:  Vincent Chan; Michael W A Chu; Howard Leong-Poi; David A Latter; Judith Hall; Kevin E Thorpe; Benoit E de Varennes; Adrian Quan; Wendy Tsang; Natasha Dhingra; Kibar Yared; Hwee Teoh; F Victor Chu; Kwan-Leung Chan; Thierry G Mesana; Kim A Connelly; Marc Ruel; Peter Jüni; C David Mazer; Subodh Verma
Journal:  BMJ Open       Date:  2017-05-30       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.